Question 2: Etanercept or adalimumab: which is a better biological therapy for juvenile idiopathic arthritis? | Archives of Disease in Childhood

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Archimedes

Question 2: Etanercept or adalimumab: which is a better biological therapy for juvenile idiopathic arthritis?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Hunter H

Question 2: Etanercept or adalimumab: which is a better biological therapy for juvenile idiopathic arthritis?

Archives of Disease in Childhood 2018;103:1087-1089.